LEUKEMIA-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=528636, encodeId=a07752863618, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：7月底投稿，审稿不到一个月小修，9月中旬返回后3天直接接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=551, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61431631434, createdName=xbh, createdTime=Wed Oct 26 10:53:00 CST 2016, time=2016-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191702, encodeId=9ac91191e0276, content=几天前刚刚投出去，昨天状态变成了decision sent to reviewers。这是送外审的意思吗？好奇怪啊。而且从live manuscript变成post decision了。作者也没收到被拒的email。大家有没有碰到类似的情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ervoOZpyH2LXoU7ibUK9xHSY6DEewrPsdic5ttTG2KKXsRBjeA5g8bkMicE9IiceAmCyxG0ekBzytPZSA/132, createdBy=78e22111987, createdName=1341f8d67dm, createdTime=Thu Feb 10 09:41:01 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057639, encodeId=fe17105e63969, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：白血病药物 经验分享：8月18号投稿，同一天“under consideration ”，10月2号“post decision+under consideration ”，10月4号拒稿无敌神坑，浪费这么多天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Mon Oct 04 17:16:29 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535550, encodeId=4052535550b0, content=求教：我的文章投过去2周了，还是under consideration, 文章是在editor那，还是已经送出去review了，请指点？哪位知道该杂志的整个投搞过程中，文章的status是怎么样的？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d69166337, createdName=sunnyphoenix, createdTime=Fri Apr 14 03:42:00 CST 2017, time=2017-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214978, encodeId=c1f312149e8cb, content=编辑发来邮件说 figures are heavily overloaded, each figure with >3 subfigures count twice，有前辈知道是什么意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/03/27/1bb8bc08cd0e022fc455fa56c7d775c4.jpg, createdBy=601c2042876, createdName=红军范爱浦, createdTime=Wed Apr 27 09:55:33 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219682, encodeId=1037121968202, content=审稿速度:4.0 偏重的研究方向：机理;白血病药物 经验分享：审稿三个月，两个审稿人给的意见是大修，编辑直接拒了。比起机制他们更看重功能的样子。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=779a5593142, createdName=gkswnd, createdTime=Sun May 15 00:01:51 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094691, encodeId=63d2109469194, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094692, encodeId=062310946920a, content=researcharticle和其它文章类型有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566792, encodeId=4ef6566e922a, content=投了10天了，还是under consideration。不知道这个杂志审稿周期多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OKR1KngRZQNYaFlsRvF3xQWibbrZrcAm9eIBVLEmUiaKsH8yUia3j8aCwwNLibGhPpBwAcEqdVwcC9ymAibfpKC5yNQ/132, createdBy=a3e12538584, createdName=tank', createdTime=Fri Feb 15 18:41:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575410, encodeId=27845e541068, content=一审审了一个月。给了60天修回今天回去了不知道多久接收。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epO9VOvOZJjg2P7fag0bnHJrkLRHJMdPBTCLH2nCTicNh2v7xatCBDVoXw1wze6Rk109HE4OnFvDUA/132, createdBy=8f782185877, createdName=蒋咚咚咚鹏, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=)]

2016-10-26 xbh

审稿速度:1.0 | 投稿命中率:25.0
经验分享：7月底投稿，审稿不到一个月小修，9月中旬返回后3天直接接受！

551 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=528636, encodeId=a07752863618, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：7月底投稿，审稿不到一个月小修，9月中旬返回后3天直接接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=551, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61431631434, createdName=xbh, createdTime=Wed Oct 26 10:53:00 CST 2016, time=2016-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191702, encodeId=9ac91191e0276, content=几天前刚刚投出去，昨天状态变成了decision sent to reviewers。这是送外审的意思吗？好奇怪啊。而且从live manuscript变成post decision了。作者也没收到被拒的email。大家有没有碰到类似的情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ervoOZpyH2LXoU7ibUK9xHSY6DEewrPsdic5ttTG2KKXsRBjeA5g8bkMicE9IiceAmCyxG0ekBzytPZSA/132, createdBy=78e22111987, createdName=1341f8d67dm, createdTime=Thu Feb 10 09:41:01 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057639, encodeId=fe17105e63969, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：白血病药物 经验分享：8月18号投稿，同一天“under consideration ”，10月2号“post decision+under consideration ”，10月4号拒稿无敌神坑，浪费这么多天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Mon Oct 04 17:16:29 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535550, encodeId=4052535550b0, content=求教：我的文章投过去2周了，还是under consideration, 文章是在editor那，还是已经送出去review了，请指点？哪位知道该杂志的整个投搞过程中，文章的status是怎么样的？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d69166337, createdName=sunnyphoenix, createdTime=Fri Apr 14 03:42:00 CST 2017, time=2017-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214978, encodeId=c1f312149e8cb, content=编辑发来邮件说 figures are heavily overloaded, each figure with >3 subfigures count twice，有前辈知道是什么意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/03/27/1bb8bc08cd0e022fc455fa56c7d775c4.jpg, createdBy=601c2042876, createdName=红军范爱浦, createdTime=Wed Apr 27 09:55:33 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219682, encodeId=1037121968202, content=审稿速度:4.0 偏重的研究方向：机理;白血病药物 经验分享：审稿三个月，两个审稿人给的意见是大修，编辑直接拒了。比起机制他们更看重功能的样子。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=779a5593142, createdName=gkswnd, createdTime=Sun May 15 00:01:51 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094691, encodeId=63d2109469194, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094692, encodeId=062310946920a, content=researcharticle和其它文章类型有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566792, encodeId=4ef6566e922a, content=投了10天了，还是under consideration。不知道这个杂志审稿周期多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OKR1KngRZQNYaFlsRvF3xQWibbrZrcAm9eIBVLEmUiaKsH8yUia3j8aCwwNLibGhPpBwAcEqdVwcC9ymAibfpKC5yNQ/132, createdBy=a3e12538584, createdName=tank', createdTime=Fri Feb 15 18:41:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575410, encodeId=27845e541068, content=一审审了一个月。给了60天修回今天回去了不知道多久接收。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epO9VOvOZJjg2P7fag0bnHJrkLRHJMdPBTCLH2nCTicNh2v7xatCBDVoXw1wze6Rk109HE4OnFvDUA/132, createdBy=8f782185877, createdName=蒋咚咚咚鹏, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=)]

2022-02-10 1341f8d67dm

几天前刚刚投出去，昨天状态变成了decision sent to reviewers。这是送外审的意思吗？好奇怪啊。而且从live manuscript变成post decision了。作者也没收到被拒的email。大家有没有碰到类似的情况啊？

175 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=528636, encodeId=a07752863618, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：7月底投稿，审稿不到一个月小修，9月中旬返回后3天直接接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=551, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61431631434, createdName=xbh, createdTime=Wed Oct 26 10:53:00 CST 2016, time=2016-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191702, encodeId=9ac91191e0276, content=几天前刚刚投出去，昨天状态变成了decision sent to reviewers。这是送外审的意思吗？好奇怪啊。而且从live manuscript变成post decision了。作者也没收到被拒的email。大家有没有碰到类似的情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ervoOZpyH2LXoU7ibUK9xHSY6DEewrPsdic5ttTG2KKXsRBjeA5g8bkMicE9IiceAmCyxG0ekBzytPZSA/132, createdBy=78e22111987, createdName=1341f8d67dm, createdTime=Thu Feb 10 09:41:01 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057639, encodeId=fe17105e63969, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：白血病药物 经验分享：8月18号投稿，同一天“under consideration ”，10月2号“post decision+under consideration ”，10月4号拒稿无敌神坑，浪费这么多天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Mon Oct 04 17:16:29 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535550, encodeId=4052535550b0, content=求教：我的文章投过去2周了，还是under consideration, 文章是在editor那，还是已经送出去review了，请指点？哪位知道该杂志的整个投搞过程中，文章的status是怎么样的？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d69166337, createdName=sunnyphoenix, createdTime=Fri Apr 14 03:42:00 CST 2017, time=2017-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214978, encodeId=c1f312149e8cb, content=编辑发来邮件说 figures are heavily overloaded, each figure with >3 subfigures count twice，有前辈知道是什么意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/03/27/1bb8bc08cd0e022fc455fa56c7d775c4.jpg, createdBy=601c2042876, createdName=红军范爱浦, createdTime=Wed Apr 27 09:55:33 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219682, encodeId=1037121968202, content=审稿速度:4.0 偏重的研究方向：机理;白血病药物 经验分享：审稿三个月，两个审稿人给的意见是大修，编辑直接拒了。比起机制他们更看重功能的样子。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=779a5593142, createdName=gkswnd, createdTime=Sun May 15 00:01:51 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094691, encodeId=63d2109469194, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094692, encodeId=062310946920a, content=researcharticle和其它文章类型有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566792, encodeId=4ef6566e922a, content=投了10天了，还是under consideration。不知道这个杂志审稿周期多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OKR1KngRZQNYaFlsRvF3xQWibbrZrcAm9eIBVLEmUiaKsH8yUia3j8aCwwNLibGhPpBwAcEqdVwcC9ymAibfpKC5yNQ/132, createdBy=a3e12538584, createdName=tank', createdTime=Fri Feb 15 18:41:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575410, encodeId=27845e541068, content=一审审了一个月。给了60天修回今天回去了不知道多久接收。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epO9VOvOZJjg2P7fag0bnHJrkLRHJMdPBTCLH2nCTicNh2v7xatCBDVoXw1wze6Rk109HE4OnFvDUA/132, createdBy=8f782185877, createdName=蒋咚咚咚鹏, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=)]

2021-10-04 一只虫虫

审稿速度:2.0 | 投稿命中率:5.0
偏重的研究方向：白血病药物
经验分享：8月18号投稿，同一天“under consideration ”，10月2号“post decision+under consideration ”，10月4号拒稿无敌神坑，浪费这么多天

191 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=528636, encodeId=a07752863618, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：7月底投稿，审稿不到一个月小修，9月中旬返回后3天直接接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=551, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61431631434, createdName=xbh, createdTime=Wed Oct 26 10:53:00 CST 2016, time=2016-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191702, encodeId=9ac91191e0276, content=几天前刚刚投出去，昨天状态变成了decision sent to reviewers。这是送外审的意思吗？好奇怪啊。而且从live manuscript变成post decision了。作者也没收到被拒的email。大家有没有碰到类似的情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ervoOZpyH2LXoU7ibUK9xHSY6DEewrPsdic5ttTG2KKXsRBjeA5g8bkMicE9IiceAmCyxG0ekBzytPZSA/132, createdBy=78e22111987, createdName=1341f8d67dm, createdTime=Thu Feb 10 09:41:01 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057639, encodeId=fe17105e63969, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：白血病药物 经验分享：8月18号投稿，同一天“under consideration ”，10月2号“post decision+under consideration ”，10月4号拒稿无敌神坑，浪费这么多天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Mon Oct 04 17:16:29 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535550, encodeId=4052535550b0, content=求教：我的文章投过去2周了，还是under consideration, 文章是在editor那，还是已经送出去review了，请指点？哪位知道该杂志的整个投搞过程中，文章的status是怎么样的？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d69166337, createdName=sunnyphoenix, createdTime=Fri Apr 14 03:42:00 CST 2017, time=2017-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214978, encodeId=c1f312149e8cb, content=编辑发来邮件说 figures are heavily overloaded, each figure with >3 subfigures count twice，有前辈知道是什么意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/03/27/1bb8bc08cd0e022fc455fa56c7d775c4.jpg, createdBy=601c2042876, createdName=红军范爱浦, createdTime=Wed Apr 27 09:55:33 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219682, encodeId=1037121968202, content=审稿速度:4.0 偏重的研究方向：机理;白血病药物 经验分享：审稿三个月，两个审稿人给的意见是大修，编辑直接拒了。比起机制他们更看重功能的样子。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=779a5593142, createdName=gkswnd, createdTime=Sun May 15 00:01:51 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094691, encodeId=63d2109469194, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094692, encodeId=062310946920a, content=researcharticle和其它文章类型有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566792, encodeId=4ef6566e922a, content=投了10天了，还是under consideration。不知道这个杂志审稿周期多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OKR1KngRZQNYaFlsRvF3xQWibbrZrcAm9eIBVLEmUiaKsH8yUia3j8aCwwNLibGhPpBwAcEqdVwcC9ymAibfpKC5yNQ/132, createdBy=a3e12538584, createdName=tank', createdTime=Fri Feb 15 18:41:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575410, encodeId=27845e541068, content=一审审了一个月。给了60天修回今天回去了不知道多久接收。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epO9VOvOZJjg2P7fag0bnHJrkLRHJMdPBTCLH2nCTicNh2v7xatCBDVoXw1wze6Rk109HE4OnFvDUA/132, createdBy=8f782185877, createdName=蒋咚咚咚鹏, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=)]

2017-04-14 sunnyphoenix

求教：我的文章投过去2周了，还是under consideration, 文章是在editor那，还是已经送出去review了，请指点？哪位知道该杂志的整个投搞过程中，文章的status是怎么样的？谢谢

429 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=528636, encodeId=a07752863618, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：7月底投稿，审稿不到一个月小修，9月中旬返回后3天直接接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=551, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61431631434, createdName=xbh, createdTime=Wed Oct 26 10:53:00 CST 2016, time=2016-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191702, encodeId=9ac91191e0276, content=几天前刚刚投出去，昨天状态变成了decision sent to reviewers。这是送外审的意思吗？好奇怪啊。而且从live manuscript变成post decision了。作者也没收到被拒的email。大家有没有碰到类似的情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ervoOZpyH2LXoU7ibUK9xHSY6DEewrPsdic5ttTG2KKXsRBjeA5g8bkMicE9IiceAmCyxG0ekBzytPZSA/132, createdBy=78e22111987, createdName=1341f8d67dm, createdTime=Thu Feb 10 09:41:01 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057639, encodeId=fe17105e63969, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：白血病药物 经验分享：8月18号投稿，同一天“under consideration ”，10月2号“post decision+under consideration ”，10月4号拒稿无敌神坑，浪费这么多天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Mon Oct 04 17:16:29 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535550, encodeId=4052535550b0, content=求教：我的文章投过去2周了，还是under consideration, 文章是在editor那，还是已经送出去review了，请指点？哪位知道该杂志的整个投搞过程中，文章的status是怎么样的？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d69166337, createdName=sunnyphoenix, createdTime=Fri Apr 14 03:42:00 CST 2017, time=2017-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214978, encodeId=c1f312149e8cb, content=编辑发来邮件说 figures are heavily overloaded, each figure with >3 subfigures count twice，有前辈知道是什么意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/03/27/1bb8bc08cd0e022fc455fa56c7d775c4.jpg, createdBy=601c2042876, createdName=红军范爱浦, createdTime=Wed Apr 27 09:55:33 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219682, encodeId=1037121968202, content=审稿速度:4.0 偏重的研究方向：机理;白血病药物 经验分享：审稿三个月，两个审稿人给的意见是大修，编辑直接拒了。比起机制他们更看重功能的样子。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=779a5593142, createdName=gkswnd, createdTime=Sun May 15 00:01:51 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094691, encodeId=63d2109469194, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094692, encodeId=062310946920a, content=researcharticle和其它文章类型有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566792, encodeId=4ef6566e922a, content=投了10天了，还是under consideration。不知道这个杂志审稿周期多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OKR1KngRZQNYaFlsRvF3xQWibbrZrcAm9eIBVLEmUiaKsH8yUia3j8aCwwNLibGhPpBwAcEqdVwcC9ymAibfpKC5yNQ/132, createdBy=a3e12538584, createdName=tank', createdTime=Fri Feb 15 18:41:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575410, encodeId=27845e541068, content=一审审了一个月。给了60天修回今天回去了不知道多久接收。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epO9VOvOZJjg2P7fag0bnHJrkLRHJMdPBTCLH2nCTicNh2v7xatCBDVoXw1wze6Rk109HE4OnFvDUA/132, createdBy=8f782185877, createdName=蒋咚咚咚鹏, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=)]

2022-04-27 红军范爱浦

编辑发来邮件说 figures are heavily overloaded, each figure with >3 subfigures count twice，有前辈知道是什么意思吗？

135 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=528636, encodeId=a07752863618, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：7月底投稿，审稿不到一个月小修，9月中旬返回后3天直接接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=551, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61431631434, createdName=xbh, createdTime=Wed Oct 26 10:53:00 CST 2016, time=2016-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191702, encodeId=9ac91191e0276, content=几天前刚刚投出去，昨天状态变成了decision sent to reviewers。这是送外审的意思吗？好奇怪啊。而且从live manuscript变成post decision了。作者也没收到被拒的email。大家有没有碰到类似的情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ervoOZpyH2LXoU7ibUK9xHSY6DEewrPsdic5ttTG2KKXsRBjeA5g8bkMicE9IiceAmCyxG0ekBzytPZSA/132, createdBy=78e22111987, createdName=1341f8d67dm, createdTime=Thu Feb 10 09:41:01 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057639, encodeId=fe17105e63969, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：白血病药物 经验分享：8月18号投稿，同一天“under consideration ”，10月2号“post decision+under consideration ”，10月4号拒稿无敌神坑，浪费这么多天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Mon Oct 04 17:16:29 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535550, encodeId=4052535550b0, content=求教：我的文章投过去2周了，还是under consideration, 文章是在editor那，还是已经送出去review了，请指点？哪位知道该杂志的整个投搞过程中，文章的status是怎么样的？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d69166337, createdName=sunnyphoenix, createdTime=Fri Apr 14 03:42:00 CST 2017, time=2017-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214978, encodeId=c1f312149e8cb, content=编辑发来邮件说 figures are heavily overloaded, each figure with >3 subfigures count twice，有前辈知道是什么意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/03/27/1bb8bc08cd0e022fc455fa56c7d775c4.jpg, createdBy=601c2042876, createdName=红军范爱浦, createdTime=Wed Apr 27 09:55:33 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219682, encodeId=1037121968202, content=审稿速度:4.0 偏重的研究方向：机理;白血病药物 经验分享：审稿三个月，两个审稿人给的意见是大修，编辑直接拒了。比起机制他们更看重功能的样子。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=779a5593142, createdName=gkswnd, createdTime=Sun May 15 00:01:51 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094691, encodeId=63d2109469194, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094692, encodeId=062310946920a, content=researcharticle和其它文章类型有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566792, encodeId=4ef6566e922a, content=投了10天了，还是under consideration。不知道这个杂志审稿周期多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OKR1KngRZQNYaFlsRvF3xQWibbrZrcAm9eIBVLEmUiaKsH8yUia3j8aCwwNLibGhPpBwAcEqdVwcC9ymAibfpKC5yNQ/132, createdBy=a3e12538584, createdName=tank', createdTime=Fri Feb 15 18:41:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575410, encodeId=27845e541068, content=一审审了一个月。给了60天修回今天回去了不知道多久接收。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epO9VOvOZJjg2P7fag0bnHJrkLRHJMdPBTCLH2nCTicNh2v7xatCBDVoXw1wze6Rk109HE4OnFvDUA/132, createdBy=8f782185877, createdName=蒋咚咚咚鹏, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=)]

2022-05-15 gkswnd

审稿速度:4.0
偏重的研究方向：机理;白血病药物
经验分享：审稿三个月，两个审稿人给的意见是大修，编辑直接拒了。比起机制他们更看重功能的样子。

0 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=528636, encodeId=a07752863618, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：7月底投稿，审稿不到一个月小修，9月中旬返回后3天直接接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=551, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61431631434, createdName=xbh, createdTime=Wed Oct 26 10:53:00 CST 2016, time=2016-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191702, encodeId=9ac91191e0276, content=几天前刚刚投出去，昨天状态变成了decision sent to reviewers。这是送外审的意思吗？好奇怪啊。而且从live manuscript变成post decision了。作者也没收到被拒的email。大家有没有碰到类似的情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ervoOZpyH2LXoU7ibUK9xHSY6DEewrPsdic5ttTG2KKXsRBjeA5g8bkMicE9IiceAmCyxG0ekBzytPZSA/132, createdBy=78e22111987, createdName=1341f8d67dm, createdTime=Thu Feb 10 09:41:01 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057639, encodeId=fe17105e63969, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：白血病药物 经验分享：8月18号投稿，同一天“under consideration ”，10月2号“post decision+under consideration ”，10月4号拒稿无敌神坑，浪费这么多天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Mon Oct 04 17:16:29 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535550, encodeId=4052535550b0, content=求教：我的文章投过去2周了，还是under consideration, 文章是在editor那，还是已经送出去review了，请指点？哪位知道该杂志的整个投搞过程中，文章的status是怎么样的？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d69166337, createdName=sunnyphoenix, createdTime=Fri Apr 14 03:42:00 CST 2017, time=2017-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214978, encodeId=c1f312149e8cb, content=编辑发来邮件说 figures are heavily overloaded, each figure with >3 subfigures count twice，有前辈知道是什么意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/03/27/1bb8bc08cd0e022fc455fa56c7d775c4.jpg, createdBy=601c2042876, createdName=红军范爱浦, createdTime=Wed Apr 27 09:55:33 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219682, encodeId=1037121968202, content=审稿速度:4.0 偏重的研究方向：机理;白血病药物 经验分享：审稿三个月，两个审稿人给的意见是大修，编辑直接拒了。比起机制他们更看重功能的样子。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=779a5593142, createdName=gkswnd, createdTime=Sun May 15 00:01:51 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094691, encodeId=63d2109469194, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094692, encodeId=062310946920a, content=researcharticle和其它文章类型有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566792, encodeId=4ef6566e922a, content=投了10天了，还是under consideration。不知道这个杂志审稿周期多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OKR1KngRZQNYaFlsRvF3xQWibbrZrcAm9eIBVLEmUiaKsH8yUia3j8aCwwNLibGhPpBwAcEqdVwcC9ymAibfpKC5yNQ/132, createdBy=a3e12538584, createdName=tank', createdTime=Fri Feb 15 18:41:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575410, encodeId=27845e541068, content=一审审了一个月。给了60天修回今天回去了不知道多久接收。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epO9VOvOZJjg2P7fag0bnHJrkLRHJMdPBTCLH2nCTicNh2v7xatCBDVoXw1wze6Rk109HE4OnFvDUA/132, createdBy=8f782185877, createdName=蒋咚咚咚鹏, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=)]

2021-12-28 rayms

什么是Protocol？

178 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=528636, encodeId=a07752863618, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：7月底投稿，审稿不到一个月小修，9月中旬返回后3天直接接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=551, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61431631434, createdName=xbh, createdTime=Wed Oct 26 10:53:00 CST 2016, time=2016-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191702, encodeId=9ac91191e0276, content=几天前刚刚投出去，昨天状态变成了decision sent to reviewers。这是送外审的意思吗？好奇怪啊。而且从live manuscript变成post decision了。作者也没收到被拒的email。大家有没有碰到类似的情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ervoOZpyH2LXoU7ibUK9xHSY6DEewrPsdic5ttTG2KKXsRBjeA5g8bkMicE9IiceAmCyxG0ekBzytPZSA/132, createdBy=78e22111987, createdName=1341f8d67dm, createdTime=Thu Feb 10 09:41:01 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057639, encodeId=fe17105e63969, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：白血病药物 经验分享：8月18号投稿，同一天“under consideration ”，10月2号“post decision+under consideration ”，10月4号拒稿无敌神坑，浪费这么多天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Mon Oct 04 17:16:29 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535550, encodeId=4052535550b0, content=求教：我的文章投过去2周了，还是under consideration, 文章是在editor那，还是已经送出去review了，请指点？哪位知道该杂志的整个投搞过程中，文章的status是怎么样的？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d69166337, createdName=sunnyphoenix, createdTime=Fri Apr 14 03:42:00 CST 2017, time=2017-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214978, encodeId=c1f312149e8cb, content=编辑发来邮件说 figures are heavily overloaded, each figure with >3 subfigures count twice，有前辈知道是什么意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/03/27/1bb8bc08cd0e022fc455fa56c7d775c4.jpg, createdBy=601c2042876, createdName=红军范爱浦, createdTime=Wed Apr 27 09:55:33 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219682, encodeId=1037121968202, content=审稿速度:4.0 偏重的研究方向：机理;白血病药物 经验分享：审稿三个月，两个审稿人给的意见是大修，编辑直接拒了。比起机制他们更看重功能的样子。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=779a5593142, createdName=gkswnd, createdTime=Sun May 15 00:01:51 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094691, encodeId=63d2109469194, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094692, encodeId=062310946920a, content=researcharticle和其它文章类型有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566792, encodeId=4ef6566e922a, content=投了10天了，还是under consideration。不知道这个杂志审稿周期多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OKR1KngRZQNYaFlsRvF3xQWibbrZrcAm9eIBVLEmUiaKsH8yUia3j8aCwwNLibGhPpBwAcEqdVwcC9ymAibfpKC5yNQ/132, createdBy=a3e12538584, createdName=tank', createdTime=Fri Feb 15 18:41:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575410, encodeId=27845e541068, content=一审审了一个月。给了60天修回今天回去了不知道多久接收。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epO9VOvOZJjg2P7fag0bnHJrkLRHJMdPBTCLH2nCTicNh2v7xatCBDVoXw1wze6Rk109HE4OnFvDUA/132, createdBy=8f782185877, createdName=蒋咚咚咚鹏, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=)]

2021-12-29 Gym璨烨

researcharticle和其它文章类型有什么区别？

183 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=528636, encodeId=a07752863618, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：7月底投稿，审稿不到一个月小修，9月中旬返回后3天直接接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=551, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61431631434, createdName=xbh, createdTime=Wed Oct 26 10:53:00 CST 2016, time=2016-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191702, encodeId=9ac91191e0276, content=几天前刚刚投出去，昨天状态变成了decision sent to reviewers。这是送外审的意思吗？好奇怪啊。而且从live manuscript变成post decision了。作者也没收到被拒的email。大家有没有碰到类似的情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ervoOZpyH2LXoU7ibUK9xHSY6DEewrPsdic5ttTG2KKXsRBjeA5g8bkMicE9IiceAmCyxG0ekBzytPZSA/132, createdBy=78e22111987, createdName=1341f8d67dm, createdTime=Thu Feb 10 09:41:01 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057639, encodeId=fe17105e63969, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：白血病药物 经验分享：8月18号投稿，同一天“under consideration ”，10月2号“post decision+under consideration ”，10月4号拒稿无敌神坑，浪费这么多天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Mon Oct 04 17:16:29 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535550, encodeId=4052535550b0, content=求教：我的文章投过去2周了，还是under consideration, 文章是在editor那，还是已经送出去review了，请指点？哪位知道该杂志的整个投搞过程中，文章的status是怎么样的？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d69166337, createdName=sunnyphoenix, createdTime=Fri Apr 14 03:42:00 CST 2017, time=2017-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214978, encodeId=c1f312149e8cb, content=编辑发来邮件说 figures are heavily overloaded, each figure with >3 subfigures count twice，有前辈知道是什么意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/03/27/1bb8bc08cd0e022fc455fa56c7d775c4.jpg, createdBy=601c2042876, createdName=红军范爱浦, createdTime=Wed Apr 27 09:55:33 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219682, encodeId=1037121968202, content=审稿速度:4.0 偏重的研究方向：机理;白血病药物 经验分享：审稿三个月，两个审稿人给的意见是大修，编辑直接拒了。比起机制他们更看重功能的样子。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=779a5593142, createdName=gkswnd, createdTime=Sun May 15 00:01:51 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094691, encodeId=63d2109469194, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094692, encodeId=062310946920a, content=researcharticle和其它文章类型有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566792, encodeId=4ef6566e922a, content=投了10天了，还是under consideration。不知道这个杂志审稿周期多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OKR1KngRZQNYaFlsRvF3xQWibbrZrcAm9eIBVLEmUiaKsH8yUia3j8aCwwNLibGhPpBwAcEqdVwcC9ymAibfpKC5yNQ/132, createdBy=a3e12538584, createdName=tank', createdTime=Fri Feb 15 18:41:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575410, encodeId=27845e541068, content=一审审了一个月。给了60天修回今天回去了不知道多久接收。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epO9VOvOZJjg2P7fag0bnHJrkLRHJMdPBTCLH2nCTicNh2v7xatCBDVoXw1wze6Rk109HE4OnFvDUA/132, createdBy=8f782185877, createdName=蒋咚咚咚鹏, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=)]

2019-02-15 tank'

投了10天了，还是under consideration。不知道这个杂志审稿周期多久啊

314 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=528636, encodeId=a07752863618, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：7月底投稿，审稿不到一个月小修，9月中旬返回后3天直接接受！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=551, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61431631434, createdName=xbh, createdTime=Wed Oct 26 10:53:00 CST 2016, time=2016-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191702, encodeId=9ac91191e0276, content=几天前刚刚投出去，昨天状态变成了decision sent to reviewers。这是送外审的意思吗？好奇怪啊。而且从live manuscript变成post decision了。作者也没收到被拒的email。大家有没有碰到类似的情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ervoOZpyH2LXoU7ibUK9xHSY6DEewrPsdic5ttTG2KKXsRBjeA5g8bkMicE9IiceAmCyxG0ekBzytPZSA/132, createdBy=78e22111987, createdName=1341f8d67dm, createdTime=Thu Feb 10 09:41:01 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057639, encodeId=fe17105e63969, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：白血病药物 经验分享：8月18号投稿，同一天“under consideration ”，10月2号“post decision+under consideration ”，10月4号拒稿无敌神坑，浪费这么多天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Mon Oct 04 17:16:29 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535550, encodeId=4052535550b0, content=求教：我的文章投过去2周了，还是under consideration, 文章是在editor那，还是已经送出去review了，请指点？哪位知道该杂志的整个投搞过程中，文章的status是怎么样的？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d69166337, createdName=sunnyphoenix, createdTime=Fri Apr 14 03:42:00 CST 2017, time=2017-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214978, encodeId=c1f312149e8cb, content=编辑发来邮件说 figures are heavily overloaded, each figure with >3 subfigures count twice，有前辈知道是什么意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/03/27/1bb8bc08cd0e022fc455fa56c7d775c4.jpg, createdBy=601c2042876, createdName=红军范爱浦, createdTime=Wed Apr 27 09:55:33 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219682, encodeId=1037121968202, content=审稿速度:4.0 偏重的研究方向：机理;白血病药物 经验分享：审稿三个月，两个审稿人给的意见是大修，编辑直接拒了。比起机制他们更看重功能的样子。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=779a5593142, createdName=gkswnd, createdTime=Sun May 15 00:01:51 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094691, encodeId=63d2109469194, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094692, encodeId=062310946920a, content=researcharticle和其它文章类型有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566792, encodeId=4ef6566e922a, content=投了10天了，还是under consideration。不知道这个杂志审稿周期多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OKR1KngRZQNYaFlsRvF3xQWibbrZrcAm9eIBVLEmUiaKsH8yUia3j8aCwwNLibGhPpBwAcEqdVwcC9ymAibfpKC5yNQ/132, createdBy=a3e12538584, createdName=tank', createdTime=Fri Feb 15 18:41:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575410, encodeId=27845e541068, content=一审审了一个月。给了60天修回今天回去了不知道多久接收。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epO9VOvOZJjg2P7fag0bnHJrkLRHJMdPBTCLH2nCTicNh2v7xatCBDVoXw1wze6Rk109HE4OnFvDUA/132, createdBy=8f782185877, createdName=蒋咚咚咚鹏, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=)]

2019-08-27 蒋咚咚咚鹏

一审审了一个月。给了60天修回今天回去了不知道多久接收。。。

281 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务